Clinical Trial Update: Second Generation DICART Prototype Validation [NA]

View source ↗

Summary

Completed update on the second generation DICART prototype validation trial conducted by Hospices Civils de Lyon for acute circulatory failure and shock.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Circulatory Failure
• Shock

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Acute Circulatory Failure, Shock | NA | Status: COMPLETED